GuideAI Health: How Is AI Helping Detect Vascular Disease Earlier?

GuideAI Health uses FDA-cleared artificial intelligence to help identify vascular disease earlier, supporting faster diagnosis and improved patient care.

Vascular disease affects millions of Americans and is estimated to cost the U.S. healthcare system more than $500 billion annually*. Early detection remains one of the biggest challenges, as many patients are diagnosed only after the disease has progressed. GuideAI Health is addressing this need through FDA-cleared artificial intelligence designed to help clinicians detect vascular disease sooner and support earlier intervention.

By combining AI-powered screening with existing clinical workflows, GuideAI Health aims to improve diagnostic efficiency while helping healthcare providers identify at-risk patients more quickly. As healthcare systems continue adopting artificial intelligence to improve outcomes and reduce costs, the company is positioning at the intersection of digital health, preventative care, and medical technology.

For more information on GuideAI Health, please click the requestinvestor info button.

*Estimated annual U.S. healthcare costs associated with vascular disease. Source: J Am Heart Assoc. 2018.

‍